We are live on ! Find out more
PKBOW

Peak Bio, Inc. Warrant
PKBOW

Delisted

PKBOW was delisted on the 5th of January, 2023.

17 hedge funds and large institutions have $613K invested in Peak Bio, Inc. Warrant in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1717 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

13% less capital invested

Capital invested by funds: $701K → $613K (-$88K)

Holders
17
Holders Change
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
-$66K

PKBOW Hedge Fund Activity: Q3 2022 in Review

17 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q3 2022, worth a combined $613K — down 13% from $701K a quarter earlier.

Fund positioning in PKBOW was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Cohen & Co Financial Management, opening a new position worth an estimated $70.8K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $66K sold.

  • 17 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $613K of Peak Bio, Inc. Warrant stock for Q3 2022, down 13% quarter-over-quarter.
  • 1 fund opened new Peak Bio, Inc. Warrant positions in Q3 2022 and 1 closed out, a net change of 0 holders.
  • The largest Peak Bio, Inc. Warrant buyer in Q3 2022 was Cohen & Co Financial Management, an estimated $70.8K added.
  • The largest Peak Bio, Inc. Warrant seller in Q3 2022 was K2 Principal Fund, an estimated $66K sold.

Based on aggregated 13F filings for Q3 2022.